Millimeter-wave Radar for Health Market - Global Forecast 2026-2032

List of Tables

The Millimeter-wave Radar for Health Market is projected to grow by USD 4.33 billion at a CAGR of 7.30% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 2.64 billion
Estimated Year [2026]	USD 2.80 billion
Forecast Year [2032]	USD 4.33 billion
CAGR (%)	7.30%

Millimeter-Wave Radar for Health: Executive Overview

Millimeter-wave radar is gaining relevance in healthcare because it can detect motion, respiration, heart-related micro-movements, and presence without requiring physical contact. Its value is particularly evident in applications where continuous observation, patient comfort, privacy, or operation through clothing and bedding are important. The technology complements, rather than universally replaces, cameras, wearable sensors, clinical monitors, and other diagnostic tools. Adoption depends on clinical validation, integration with care workflows, cybersecurity, affordability, and compliance with medical-device requirements.

Healthcare Is Shifting Toward Contactless, Continuous Monitoring

The healthcare landscape is moving toward remote care, hospital-at-home models, ambient monitoring, and earlier detection of patient deterioration. These shifts create demand for sensing technologies that reduce the burden of attached devices while supporting observation in bedrooms, wards, rehabilitation settings, and assisted-living environments. Millimeter-wave radar can contribute by measuring movement and vital-sign-related patterns in low-light or privacy-sensitive environments. However, reliable deployment requires careful management of body position, motion artifacts, multipath reflections, room configuration, skin and clothing effects, and differences among patient populations.

Artificial Intelligence Turns Radar Signals Into Clinically Useful Context

Artificial intelligence can improve the interpretation of radar returns by separating respiration, gross movement, posture, and other signal components in complex environments. Machine-learning models may support anomaly detection, fall-risk assessment, sleep and activity analysis, occupancy awareness, and prioritization of clinical review. The strongest implementations combine radar data with contextual information and established clinical protocols rather than presenting isolated algorithmic outputs as diagnoses. Leaders should require representative training data, transparent performance testing, drift monitoring, human oversight, and safeguards against bias, false alarms, data leakage, and model behavior that cannot be explained to clinicians or patients.

Regional Dynamics: Regulation, Care Models, and Infrastructure Shape Adoption

North America benefits from advanced digital-health infrastructure, substantial remote-monitoring activity, and mature medical-device governance, while procurement and reimbursement requirements remain important barriers. Europe emphasizes privacy, interoperability, clinical evidence, and regulatory conformity across diverse health systems. Asia-Pacific combines strong electronics capabilities and varied healthcare environments, creating opportunities for both hospitals and home-based care. Latin America is likely to favor applications that address staffing constraints, chronic-care access, and cost-sensitive deployment. The Middle East is developing digitally enabled hospitals and connected-care programs, although localization and workforce readiness are critical. Africa presents meaningful use cases in remote monitoring and resource-constrained settings, but connectivity, maintenance, power reliability, and affordability strongly influence practical adoption.

Group Insights: Alliances and Economic Blocs Influence Standards and Deployment

ASEAN markets offer a diverse pathway for applications spanning urban hospitals, elder care, and remote monitoring, with interoperability and affordability central to scale. BRICS countries provide broad clinical, manufacturing, and public-health contexts, but regulatory pathways and infrastructure vary significantly. The European Union places strong emphasis on privacy, conformity assessment, data governance, and cross-border interoperability. G7 healthcare systems generally have stronger research capacity and digital infrastructure, yet face demanding evidence and procurement standards. GCC countries are investing in technologically advanced care environments, where localization, cybersecurity, and integration with national health platforms matter. NATO members may benefit from mature resilience and innovation ecosystems, but civilian healthcare adoption remains governed primarily by national regulation and clinical value.

Country Insights: National Priorities Create Distinct Adoption Pathways

Australia is well suited to remote and aged-care monitoring, subject to connectivity and clinical-validation requirements. Brazil may prioritize affordable hospital, elder-care, and chronic-disease applications, while Canada's geography supports interest in remote monitoring and privacy-conscious care. China combines advanced sensing capabilities with large healthcare and elder-care needs, alongside complex regulatory and data-governance considerations. France, Germany, Italy, and Spain are shaped by European medical-device, privacy, reimbursement, and interoperability expectations, with opportunities in hospitals, rehabilitation, and assisted living. India's scale and uneven access favor cost-efficient solutions designed for varied clinical settings. Japan and South Korea have strong relevance in aging, home care, robotics, and smart-hospital environments. Mexico may benefit from applications addressing access and workforce limitations. Russia's pathway is influenced by domestic technology availability, health-system priorities, and regulatory conditions. The United Kingdom has a strong digital-health and clinical-research base, but adoption depends on evidence, procurement, and health-service integration. The United States offers extensive research and care-delivery opportunities, with demanding requirements for safety, privacy, cybersecurity, and clinical utility.

Action Priorities for Leaders Building Reliable Radar-Based Health Solutions

Industry leaders should begin with clearly defined clinical or operational problems where contactless sensing provides a measurable advantage. They should validate performance across ages, body types, skin tones, mobility levels, room layouts, and real-world sources of interference; compare results with accepted clinical references; and establish thresholds for escalation and human review. Product teams should design for privacy by minimizing raw-data retention, securing transmissions, documenting model behavior, and supporting interoperability with clinical systems. Commercial strategies should align with reimbursement, procurement, maintenance, and training realities in each target geography. Partnerships with care providers, regulators, researchers, and patient groups can improve evidence quality and trust before broad deployment.

Research Methodology: Evidence-Led Assessment of Technology and Adoption Conditions

This executive summary uses a structured qualitative assessment of millimeter-wave radar applications in healthcare. The analysis considers sensing capabilities, clinical and operational use cases, artificial-intelligence integration, implementation constraints, regulatory and privacy expectations, infrastructure readiness, and differences among regions, economic groups, and countries. Insights are framed around observable healthcare trends and technology requirements rather than numerical market estimates. A robust full study should triangulate peer-reviewed research, clinical evaluations, regulatory materials, health-system procurement evidence, standards documentation, implementation case studies, and interviews with clinicians, engineers, administrators, and patients. Findings should be tested against real-world validation data and updated as standards, clinical evidence, and deployment practices evolve.

Conclusion: Clinical Trust and Integration Will Determine Sustainable Adoption

Millimeter-wave radar offers a promising foundation for privacy-conscious, contactless health monitoring, especially where continuous observation and reduced sensor burden matter. Its long-term role will depend less on sensing novelty than on demonstrated clinical utility, dependable performance, responsible artificial intelligence, secure data practices, and integration into care workflows. Regional and national conditions will produce different adoption sequences, but the common requirement is clear: solutions must improve outcomes or efficiency without adding unacceptable clinical, operational, or ethical risk.

Product Code: MRR-961F26FD66DC

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Millimeter-wave Radar for Health Market, by Device Type

7.1. Introduction
7.2. Non-Wearable
7.3. Wearable

8. Millimeter-wave Radar for Health Market, by Technology

8.1. Introduction
8.2. Continuous Wave
8.3. Frequency-Modulated Continuous Wave
8.4. Ultra-Wideband

9. Millimeter-wave Radar for Health Market, by Offering

9.1. Introduction
9.2. Hardware
9.3. Services
9.4. Software

10. Millimeter-wave Radar for Health Market, by Frequency

10.1. Introduction
10.2. 24-30 GHz
10.3. 60-64 GHz
10.4. 77-81 GHz

11. Millimeter-wave Radar for Health Market, by Application

11.1. Introduction
11.2. Fall Detection
11.3. Sleep Monitoring
11.4. Vital Signs Monitoring
- 11.4.1. Body Temperature Monitoring
- 11.4.2. Heart Rate Monitoring
- 11.4.3. Respiratory Rate Monitoring

12. Millimeter-wave Radar for Health Market, by End User

12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
12.5. Research Institutes

13. Millimeter-wave Radar for Health Market, by Region

13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa

14. Millimeter-wave Radar for Health Market, by Group

14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO

15. Millimeter-wave Radar for Health Market, by Country

15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
- 16.2.1. Concentration Ratio (CR)
- 16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Acconeer AB
17.2. Analog Devices, Inc.
17.3. Echodyne Corp.
17.4. ifLabel Technology Co., Ltd.
17.5. Infineon Technologies AG
17.6. Murata Manufacturing Co., Ltd.
17.7. NXP Semiconductors N.V.
17.8. Qorvo, Inc.
17.9. STMicroelectronics N.V.
17.10. Texas Instruments Incorporated
17.11. Vayyar Imaging Ltd.
17.12. Xandar Kardian Inc.

18. Key Experts